These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10094612)

  • 1. Design of libraries to explore receptor sites.
    Murray CM; Cato SJ
    J Chem Inf Comput Sci; 1999; 39(1):46-50. PubMed ID: 10094612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flexibases: a way to enhance the use of molecular docking methods.
    Kearsley SK; Underwood DJ; Sheridan RP; Miller MD
    J Comput Aided Mol Des; 1994 Oct; 8(5):565-82. PubMed ID: 7876901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrostatic evaluation of isosteric analogues.
    Sayle R; Nicholls A
    J Comput Aided Mol Des; 2006 Apr; 20(4):191-208. PubMed ID: 16845506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new approach to the automatic identification of candidates for ligand receptor sites in proteins: (I). Search for pocket regions.
    Del Carpio CA; Takahashi Y; Sasaki S
    J Mol Graph; 1993 Mar; 11(1):23-9, 42. PubMed ID: 8499393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fast drug-receptor mapping by site-directed distances: a novel method of predicting new pharmacological leads.
    Smellie AS; Crippen GM; Richards WG
    J Chem Inf Comput Sci; 1991 Aug; 31(3):386-92. PubMed ID: 1939396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revisiting de novo drug design: receptor based pharmacophore screening.
    Amaravadhi H; Baek K; Yoon HS
    Curr Top Med Chem; 2014; 14(16):1890-8. PubMed ID: 25262804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacophore-based molecular docking to account for ligand flexibility.
    Joseph-McCarthy D; Thomas BE; Belmarsh M; Moustakas D; Alvarez JC
    Proteins; 2003 May; 51(2):172-88. PubMed ID: 12660987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docking flexible ligands to macromolecular receptors by molecular shape.
    DesJarlais RL; Sheridan RP; Dixon JS; Kuntz ID; Venkataraghavan R
    J Med Chem; 1986 Nov; 29(11):2149-53. PubMed ID: 3783576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a method for controlling molecular scaffold diversity in de novo ligand design.
    Todorov NP; Dean PM
    J Comput Aided Mol Des; 1997 Mar; 11(2):175-92. PubMed ID: 9089435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Library design and virtual screening using multiple 4-point pharmacophore fingerprints.
    Mason JS; Cheney DL
    Pac Symp Biocomput; 2000; ():576-87. PubMed ID: 10902205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico screening against wild-type and mutant Plasmodium falciparum dihydrofolate reductase.
    Fogel GB; Cheung M; Pittman E; Hecht D
    J Mol Graph Model; 2008 Apr; 26(7):1145-52. PubMed ID: 18037315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular perspective: methotrexate.
    Goodsell DS
    Stem Cells; 1999; 17(5):314-5. PubMed ID: 10527466
    [No Abstract]   [Full Text] [Related]  

  • 13. RASSE: a new method for structure-based drug design.
    Luo Z; Wang R; Lai L
    J Chem Inf Comput Sci; 1996; 36(6):1187-94. PubMed ID: 8941995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combinatorial approaches to synthetic receptors.
    Srinivasan N; Kilburn JD
    Curr Opin Chem Biol; 2004 Jun; 8(3):305-10. PubMed ID: 15183329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FlexE: efficient molecular docking considering protein structure variations.
    Claussen H; Buning C; Rarey M; Lengauer T
    J Mol Biol; 2001 Apr; 308(2):377-95. PubMed ID: 11327774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for compound selection.
    Olah MM; Bologa CG; Oprea TI
    Curr Drug Discov Technol; 2004 Oct; 1(3):211-20. PubMed ID: 16472248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The measurement of molecular diversity: a three-dimensional approach.
    Chapman D
    J Comput Aided Mol Des; 1996 Dec; 10(6):501-12. PubMed ID: 9007684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor-assisted combinatorial chemistry: thermodynamics and kinetics in drug discovery.
    Cheeseman JD; Corbett AD; Gleason JL; Kazlauskas RJ
    Chemistry; 2005 Mar; 11(6):1708-16. PubMed ID: 15565741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matching chemistry and shape in molecular docking.
    Shoichet BK; Kuntz ID
    Protein Eng; 1993 Sep; 6(7):723-32. PubMed ID: 7504257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PRO_SELECT: combining structure-based drug design and combinatorial chemistry for rapid lead discovery. 1. Technology.
    Murray CW; Clark DE; Auton TR; Firth MA; Li J; Sykes RA; Waszkowycz B; Westhead DR; Young SC
    J Comput Aided Mol Des; 1997 Mar; 11(2):193-207. PubMed ID: 9089436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.